Urology News and Research

Latest Urology News and Research

Dendreon initiates enrollment in DN24-02 Phase 2 trial for HER2 positive cancer

Dendreon Corporation today announced that the company has begun enrolling patients into a Phase 2 trial for DN24-02, Dendreon's investigational active cellular immunotherapy being evaluated for the treatment of HER2 positive cancer.

18 Oct 2011

Watson confirms patent challenge of generic Daytrana

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Methylphenidate Transdermal System, 10 mg/9 hrs, 15 mg/9 hrs, 20 mg/9 hrs, and 30 mg/9 hrs.

15 Oct 2011

EMKinetics initiates TranStim therapy pivotal trial for urge incontinence, overactive bladder

EMKinetics, Inc. announced today initiation of the TranStim Transdermal Neuromodulation System pivotal trial for patients suffering from urge incontinence and overactive bladder.

14 Oct 2011

University of Cape Town, UT Southwestern sign affiliation agreement

UT Southwestern Medical Center and the faculty of health sciences of the University of Cape Town in South Africa, signed a five-year affiliation agreement today to collaborate on faculty and student exchanges, joint research and training activities and other educational opportunities.

13 Oct 2011

High dose vitamin E supplements may raise risk of prostate cancer: Study

The chances of developing the disease rose by 17 per cent, even years after men stopped taking the vitamin, claim researchers. This comes right after the study which found women taking multivitamins and other supplements have an increased risk of dying.

13 Oct 2011

Intellikine commences INK1117 Phase I dose escalation study in cancer

Intellikine, Inc., a company focused on the discovery and development of innovative, small molecule drugs targeting the PI3K/mTOR pathway, announced today that the first patient has been treated in a Phase I dose escalation study of INK1117 in patients with advanced solid malignancies.

12 Oct 2011

Angle-resolved low coherence interferometry can diagnose pre-cancerous colon cells

After demonstrating that light accurately detected pre-cancerous cells in the lining of the esophagus, Duke University bioengineers turned their technology to the colon and have achieved similar results in a series of preliminary experiments.

12 Oct 2011

Two-gene DNA urine test for prostate cancer

In the current debate sparked by the recent USPSTF recommendation on PSA screening, it is clear that better biomarkers than PSA are urgently needed. One new biotechnology that may go a long way in detecting only prostate cancer and reducing unnecessary prostate cancer biopsies and possible subsequent overtreatment, is the development of a new urine test for prostate cancer.

12 Oct 2011

PSA test for prostate cancer may confuse: Experts debate its continued use

According to new research the PSA test for prostate cancer does more harm than good. This week, the United States Preventive Services Task Force is expected to announce its recommendation against routine testing for blood levels of prostate-specific antigen, the protein that can be a signal of prostate cancer.

11 Oct 2011

Selected prescription drugs contribute to 10% of lower urinary tract symptoms among men

Use of selected prescription medications, including antidepressants, antihistamines, bronchodilators, anticholinergics, sympathomimetics, and diuretics contribute to 10 percent of lower urinary tract symptoms among men according to a Kaiser Permanente study published in the Archives of Internal Medicine.

11 Oct 2011

LUGPA encourages men to speak out to preserve prostate cancer screenings

The Large Urology Group Practice Association (LUGPA), representing more than 1,800 urologists, encourages men to speak out to preserve prostate cancer screenings.

11 Oct 2011

USPSTF releases draft recommendation on prostate cancer screening

Yesterday, the United States Preventive Services Task Force released a draft recommendation that states healthy men should no longer receive a P.S.A test for prostate cancer as it often leads to unnecessary testing and procedures and does not save lives.

10 Oct 2011

Scientists discover new metabolic pathway which makes gliomas more aggressive

A research alliance of Heidelberg University Hospital and the German Cancer Research Center, jointly with colleagues of the Helmholtz Center for Environmental Research in Leipzig, have discovered a new metabolic pathway which makes malignant brain tumors (gliomas) more aggressive and weakens patients' immune systems.

7 Oct 2011

Latest findings on cancer to be presented at 10th AACR international conference

What: The 10th AACR International Conference on Frontiers in Cancer Prevention Research will bring together scientists to share the latest findings in genetics, chemoprevention and lifestyle choices that may prevent cancer.

4 Oct 2011

Study compares treatment plans for CyberKnife treatment delivery system

Radiosurgery is a non-invasive medical procedure in which focused beams of high-energy X-rays target tumors and other abnormalities in the body. A single large dose of radiation is capable of ablating a lesion that might not be amenable to surgical removal. However, some radiosurgery systems, such as the CyberKnife (CK), can be relatively time-consuming because the treatment planning requires the delivery of up to several hundred cone-shaped beams to adequately cover an irregularly shaped tumor.

3 Oct 2011

Hassenfeld family, NYU Langone unveil $50M gift to create new pediatric hospital

NYU Langone Medical Center and the Hassenfeld family unveiled a $50 million gift today that will create a comprehensive pediatric hospital at NYU Langone Medical Center.

3 Oct 2011

MDC Partners acquires majority stake in Concentric Pharma

Concentric Pharma Advertising, one of the largest and fastest-growing healthcare advertising agencies in the country, announced today that MDC Partners, Inc., has acquired a majority stake in the company.

1 Oct 2011

Lifespan researcher receives Ig Nobel Prize at Harvard University

Peter J. Snyder, Ph.D., vice president of research for Lifespan, received one of 10 Ig Nobel Prize awards during the annual ceremony last night at Harvard University.

1 Oct 2011

Kimmel Cancer Center at Jefferson celebrates two decades of caring and collaboration to beat cancer

From October forward, the Kimmel Cancer Center at Jefferson (KCC), a National Cancer Institute-designated cancer center, is celebrating 20 years of service to the community and the groundbreaking cancer research from the scientists and physicians who've provided an invaluable contribution to medical science and healthcare.

30 Sep 2011

Saw Palmetto ineffective in patients with enlarged prostate: Study

A new study showed that much cited saw-palmetto supplements for the middle aged to cope with the symptoms of an enlarged prostate might not do much at all.

28 Sep 2011